Fentanyl Transdermal System (marketed as Duragesic) Information
The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA MedWatch program, using the contact information at the bottom of this page.
Safety Information
- FDA Drug Safety Communication: FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safetyâemphasizing that accidental exposure to used patches can cause death
- Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release and Long-Acting Opioids
- Fentanyl Patch Can Be Deadly to Children
- Safe Use Initiative: Fentanyl Transdermal System âPatchesâ: Safe Disposal
Regulatory History and Labeling from Drugs@FDA
More Information
- Disposal of Unused Medicines: What You Should Know
- How to Dispose of Unused Medicines
- DEA Nationwide Prescription Drug Take-Back Initiative
- Proper disposal of fentanyl patches is critical to prevent accidental exposure
- CDER Takes Steps to End Prescription Pain Medicine Misuse, Abuse, and Addiction